Information  X 
Enter a valid email address

Scancell Holdings PLC Ord 0.1P (SCLP)

Date Time Source Announcement
17 Apr 2015 9:00 am
RNS
Poster on Moditope to be presented at AACR
24 Mar 2015 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
SCIB2 synergy with checkpoint inhibitor blockade
12 Jan 2015 7:00 am
RNS
Positive SCIB1 Phase 1/2 clinical trial update
15 Dec 2014 5:22 pm
RNS
Holding(s) in Company
10 Dec 2014 7:00 am
RNS
Half Yearly Report
22 Oct 2014 3:07 pm
RNS
Change of Registered Office
14 Oct 2014 6:19 pm
RNS
Result of AGM
  7:00 am
RNS
Appointment of Nominated Adviser and Broker
  7:00 am
RNS
AGM research and development update
30 Sep 2014 7:00 am
RNS
Present at the 14th Annual Biotech in Europe Forum
19 Sep 2014 9:57 am
RNS
Notice of AGM
12 Sep 2014 7:00 am
RNS
Presenting at Upcoming Scientific Conferences
04 Sep 2014 7:00 am
RNS
Final Results
12 Aug 2014 7:00 am
RNS
Synergy of SCIB1 with checkpoint inhibitors
19 Jun 2014 7:00 am
RNS
Director/PDMR Shareholding
06 Jun 2014 7:00 am
RNS
DNA ImmunoBody Patent Granted in United States
02 Jun 2014 7:00 am
RNS
Update on Phase 1/2 trial of SCIB1 in melanoma
15 May 2014 7:30 am
RNS
Presents latest SCIB1 data at ASCO
09 May 2014 8:30 am
RNS
Directorate Change
01 May 2014 7:00 am
RNS
Dr Sally Adams to Join as Development Director
04 Apr 2014 7:00 am
RNS
Scancell to present SCIB1 at AACR
21 Mar 2014 7:00 am
RNS
8mg Higher Dose SCIB1 Study On Track
18 Feb 2014 7:00 am
RNS
Publication of Moditope Patent
11 Feb 2014 7:00 am
RNS
SCIB1 Granted FDA Orphan Drug Status
10 Feb 2014 4:43 pm
RNS
Holding(s) in Company
06 Jan 2014 7:00 am
RNS
Nottingham Technology Grant
16 Dec 2013 7:00 am
RNS
Nottingham Trent University Cancer Protein Study
12 Dec 2013 7:00 am
RNS
DNA ImmunoBody Patent Granted in Japan
11 Dec 2013 7:00 am
RNS
Director/PDMR Shareholding
09 Dec 2013 7:00 am
RNS
Half Yearly Report
  7:00 am
RNS
New data for SCIB1 in metastatic melanoma
18 Nov 2013 7:00 am
RNS
Re Agreement with Ichor
01 Nov 2013 4:56 pm
RNS
AGM Statement
22 Oct 2013 8:00 am
RNS
Director/PDMR Shareholding
14 Oct 2013 10:10 am
RNS
Holding(s) in Company
08 Oct 2013 2:54 pm
RNS
Notice of AGM
01 Oct 2013 7:00 am
RNS
Investor Update
24 Sep 2013 7:00 am
RNS
Investor Update Agenda
10 Sep 2013 3:06 pm
RNS
Investor Day
03 Sep 2013 7:00 am
RNS
DNA ImmunoBody Patent Granted in first market
20 Aug 2013 7:00 am
RNS
Inclusion on Frankfurt Stock Exchange
12 Aug 2013 5:16 pm
RNS
Director/PDMR Shareholding
08 Aug 2013 3:15 pm
RNS
Holding(s) in Company
05 Aug 2013 2:17 pm
RNS
Holding(s) in Company
01 Aug 2013 11:39 am
RNS
Result of General Meeting
26 Jul 2013 7:00 am
RNS
Result of Open Offer
23 Jul 2013 7:00 am
RNS
Director/PDMR Shareholding
19 Jul 2013 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
12 Jul 2013 7:00 am
RNS
Research Update
10 Jul 2013 10:55 am
RNS
Annual Financial Report
09 Jul 2013 7:00 am
RNS
Proposed Firm Placing and Open Offer
  7:00 am
RNS
Final Results
09 Apr 2013 7:00 am
RNS
Appointment of Non-Executive Director
14 Mar 2013 7:00 am
RNS
Re: The Journal of Clinical Investigation Paper
27 Feb 2013 2:00 pm
RNS
Directorate Change
06 Feb 2013 7:00 am
RNS
ImmunoBody patent approved for grant in Japan
31 Jan 2013 7:00 am
RNS
Half Yearly Report
29 Jan 2013 7:00 am
RNS
Update on patient recruitment in clinical trial
12 Dec 2012 7:00 am
RNS
Directorate Change
  7:00 am
RNS
SCIB1 Trial-Higher Dose Allowed in Phase 1/2 Trial
06 Dec 2012 7:00 am
RNS
Update on SCIB1 Phase 1/2 clinical trial
03 Dec 2012 9:30 am
RNS
Holding(s) in Company
07 Nov 2012 4:02 pm
RNS
Result of AGM
12 Oct 2012 7:00 am
RNS
Final Results
08 Oct 2012 10:43 am
RNS
Holding(s) in Company
  10:43 am
RNS
Holding(s) in Company
  10:31 am
RNS
Notice of Results and Share Price Movement
03 Oct 2012 3:30 pm
RNS
Change of Advisers
10 Sep 2012 11:10 am
RNS
Holding(s) in Company
03 Sep 2012 5:39 pm
RNS
Holding(s) in Company
23 Aug 2012 7:00 am
RNS
Holding(s) in Company
20 Aug 2012 4:03 pm
RNS
Holding(s) in Company
  4:01 pm
RNS
Market Update
17 Aug 2012 9:24 am
RNS
Holding(s) in Company
15 Aug 2012 1:12 pm
RNS
Moditope Vaccine Technology Platform
19 Jun 2012 7:00 am
RNS
Long Term Treatment Approval
25 May 2012 7:00 am
RNS
Vesting of Ichor Options
02 May 2012 7:00 am
RNS
SCIB1 Update
17 Apr 2012 7:00 am
RNS
SCIB1 Trial Update
16 Apr 2012 11:34 am
RNS
Holding(s) in Company
13 Mar 2012 8:23 am
RNS
Notice of Investor Meeting
09 Mar 2012 7:00 am
RNS
Patent Approval
29 Feb 2012 3:49 pm
RNS
Change of Registered Office
31 Jan 2012 7:00 am
RNS
Half Year Results
13 Dec 2011 4:28 pm
PRN
Issue of Equity
17 Nov 2011 11:29 am
PRN
Holdings in Company
04 Nov 2011 7:00 am
PRN
Confirmation of GBP2.85 million payment
25 Oct 2011 7:00 am
PRN
Progress on possible GBP2.85m payment
20 Oct 2011 9:00 am
PRN
SCIB 1 Patent Awarded
19 Aug 2011 12:25 pm
PRN
Holding(s) in Company
18 Aug 2011 11:37 am
PRN
Appointment of Director
17 Aug 2011 7:00 am
PRN
SCIB1: Safety Review and Dose Escalation
26 Jul 2011 1:01 pm
PRN
Holding(s) in Company
25 Jul 2011 12:45 pm
PRN
AGM & EGM Statement
30 Jun 2011 11:48 am
PRN
Change of Board Structure
  11:46 am
PRN
Development of new vaccine for treating lung ca...
  11:44 am
PRN
Placing to raise �1.73 million
  11:37 am
PRN
Final Results
03 Jun 2011 7:00 am
PRN
Appointment of Broker
31 Jan 2011 8:30 am
PRN
Interim Results
  7:00 am
PRN
SCIB1: Safety Review and Dose Escalation
28 Jan 2011 7:00 am
PRN
Re: SCIB1 Clinical Trial Patient Recruitment
13 Jan 2011 7:00 am
PRN
Issue of Equity
14 Dec 2010 2:25 pm
PRN
Result of AGM
  7:00 am
PRN
AGM Statement
07 Sep 2010 11:00 am
PRN
Re: ImmuneRegen Strategic Collaboration
06 Sep 2010 7:00 am
PRN
Appointment of Broker
10 Aug 2010 7:00 am
PRN
Licence Agreement with Cancer Research Technology
14 Jul 2010 12:17 pm
PRN
Grant of Options
  9:46 am
PRN
Admission to AIM
  9:37 am
PRN
Final Results
29 Jun 2010 11:00 am
PRN
Supply Agreement - Share Options
  7:00 am
PRN
immatics Research Collaboration
15 Jun 2010 7:00 am
PRN
SCIB1 Phase I Clinical Trial Commences
04 Jun 2010 7:00 am
PRN
Strategic Collaboration - ImmuneRegen BioSciences
13 May 2010 9:43 am
PRN
Replacement - NIH Licensing Agreeme
11 May 2010 7:00 am
PRN
National Institutes of Health Licensing Agreement
10 May 2010 7:00 am
PRN
Placing
05 May 2010 7:00 am
PRN
CTA Approval for SCIB1
14 Apr 2010 7:00 am
PRN
Placing of New Ordinary Shares
29 Mar 2010 7:00 am
PRN
Results of Open Offer
10 Mar 2010 4:51 pm
PRN
Director/PDMR Shareholding
05 Mar 2010 10:22 am
PRN
Open Offer
02 Feb 2010 7:00 am
PRN
CTA for SCIB1 melanoma vaccine
29 Jan 2010 7:00 am
PRN
Interim Results
24 Nov 2009 6:01 pm
PRN
Result of AGM
17 Nov 2009 7:00 am
PRN
Appointment of PharmaNet
02 Nov 2009 7:00 am
PRN
Completion of SCIB1 cGMP Manufacture
09 Sep 2009 7:00 am
PRN
Final Results
06 Aug 2009 7:00 am
PRN
Agreement with ImmunoVaccine Technologies
16 Jul 2009 7:00 am
PRN
License of Ichor's TriGrid Electroporation Device
02 Jul 2009 7:00 am
PRN
Merck Serono Licensing Agreement
01 Jul 2009 7:00 am
PRN
Change of Advisor
26 Jan 2009 7:00 am
PRN
Scancell Receives GBP250,000 emda Grant
22 Jan 2009 7:00 am
PRN
GMP Manufacture Deal With Cobra
15 Jan 2009 7:00 am
PRN
Half-yearly Report
19 Dec 2008 12:56 pm
MKW
Issue of Equity
20 Nov 2008 7:00 am
PRN
Notice of Results
24 Sep 2008 7:01 am
MKW
Audited Final Results for the Year Ended 30 Apr...
  7:00 am
MKW
Admission and Start of Trading
 
Headlines
Top categories
Company finder